A Food and Drug Administration (FDA) advisory panel on Friday endorsed Johnson & Johnson’s coronavirus vaccine and recommended the agency grant emergency authorization, moving the nation’s third vaccine one step closer to getting into Americans’ arms.
The panel voted 22-0 that the benefits outweigh the risks for adults age 18 and older.
FDA could give the green light to the single-dose vaccine as early as Saturday. Continue reading.